The effects of antimigraine drugs on the vascular responses by-5-hydroxytryptamine and related biogenic substances on the external carotid bed of dogs: possible pharmacological implications to their antimigraine action.
D000818:Animals; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D001920:Bradykinin / Q000494:pharmacology*; D002339:Carotid Arteries / Q000187:drug effects; D002342:Carotid Artery, External / Q000187:drug effects / Q000503:physiopathology; D003533:Cyproheptadine / Q000494:pharmacology*; D004285:Dogs; D004878:Ergotamine; D005260:Female; D006632:Histamine / Q000494:pharmacology*; D008297:Male; D008784:Methysergide / Q000494:pharmacology*; D008881:Migraine Disorders / Q000188:drug therapy* / Q000503:physiopathology; D009638:Norepinephrine / Q000494:pharmacology*; D012701:Serotonin / Q000494:pharmacology*; D012702:Serotonin Antagonists
D012702:Serotonin Antagonists; D003533:Cyproheptadine; D012701:Serotonin; D006632:Histamine; D004878:Ergotamine; D001920:Bradykinin; D009638:Norepinephrine; D008784:Methysergide